Context Therapeutics Inc. - Common Stock (CNTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2021 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
CNTX on Nasdaq
Shares outstanding
91,837,471
Price per share
$2.47
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
65,197,080
Total reported value
$95,840,638
% of total 13F portfolios
0%
Share change
-3,770,886
Value change
-$5,288,639
Number of holders
42
Price from insider filings
$2.47
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Context Therapeutics Inc. - Common Stock (CNTX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MPM BioImpact LLC 12% -30% $15,698,705 -$5,918,942 10,679,391 -27% MPM BioImpact LLC 31 Dec 2025
Avidity Partners Management LP 9.9% 0% $8,913,522 +$72,083 9,200,580 +0.82% Avidity Partners Management LP 30 Sep 2025
Deep Track Capital, LP 8.3% $7,419,355 7,419,355 Deep Track Capital, LP 31 Mar 2025
Blue Owl Capital Holdings LP 8.5% $6,357,928 6,357,928 Blue Owl Capital Holdings LP 31 Dec 2024
Soleus Capital Master Fund, L.P. 5.2% $5,779,442 4,776,398 Soleus Capital Master Fund, L.P. 02 Feb 2026
GREAT POINT PARTNERS LLC 5.1% -2.4% $6,885,055 4,683,711 0% Great Point Partners, LLC 31 Dec 2025
FRANKLIN RESOURCES INC 4.5% -16% $4,003,380 4,003,380 0% Franklin Resources, Inc. 31 Mar 2025
Lehr Martin A. 2.1% $1,595,742 1,595,742 Martin Lehr 31 Dec 2024

As of 31 Dec 2025, 42 institutional investors reported holding 65,197,080 shares of Context Therapeutics Inc. - Common Stock (CNTX). This represents 71% of the company’s total 91,837,471 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Context Therapeutics Inc. - Common Stock (CNTX) together control 71% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
MPM BIOIMPACT LLC 12% 10,679,391 -27% 1.8% $15,698,705
Blue Owl Capital Holdings LP 8.1% 7,432,906 +0.34% 3.4% $10,926,372
Nextech Invest, Ltd. 8.1% 7,419,355 0% 1.1% $10,906,452
Deep Track Capital, LP 8.1% 7,419,355 0% 0.25% $10,906,452
Avidity Partners Management LP 6% 5,504,855 -39% 2.3% $8,092,137
GREAT POINT PARTNERS LLC 5.1% 4,683,711 0% 2.2% $6,885,055
FRANKLIN RESOURCES INC 4.4% 4,003,380 0% 0% $5,884,969
VANGUARD GROUP INC 4.1% 3,785,909 +8.3% 0% $5,565,287
MILLENNIUM MANAGEMENT LLC 2.8% 2,601,216 0% $3,823,788
MARSHALL WACE, LLP 2.8% 2,593,198 +7154% 0% $3,812,001
Blackstone Inc. 2.7% 2,440,330 0% 0.02% $3,587,285
Alyeska Investment Group, L.P. 1.8% 1,663,355 0% 0.01% $2,445,132
Sio Capital Management, LLC 1.5% 1,341,636 0% 0.33% $1,972,205
BlackRock, Inc. 0.92% 848,046 -0.11% 0% $1,246,628
GEODE CAPITAL MANAGEMENT, LLC 0.66% 608,462 -0.02% 0% $894,882
RENAISSANCE TECHNOLOGIES LLC 0.55% 508,329 +59% 0% $747,244
ADAR1 Capital Management, LLC 0.38% 351,094 0% 0.04% $516,108
STATE STREET CORP 0.18% 165,607 +8.5% 0% $243,442
Walleye Capital LLC 0.14% 132,786 0% 0% $195,195
HighTower Advisors, LLC 0.14% 125,852 0% 0% $185,002
Pathstone Holdings, LLC 0.12% 110,244 0% 0% $162,059
Mill Creek Capital Advisors, LLC 0.11% 104,631 0% 0% $153,808
XTX Topco Ltd 0.11% 101,605 +859% 0% $149,359
Velan Capital Investment Management LP 0.11% 100,000 0% 0.09% $147,000
Clear Harbor Asset Management, LLC 0.1% 92,804 0% 0.01% $136,422

Institutional Holders of Context Therapeutics Inc. - Common Stock (CNTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 65,197,080 $95,840,638 -$5,288,639 $1.47 42
2025 Q3 68,966,266 $66,815,968 +$689,909 $0.97 37
2025 Q2 68,619,580 $44,959,003 -$1,721,044 $0.66 39
2025 Q1 71,405,968 $43,712,940 -$1,099,517 $0.61 42
2024 Q4 72,797,034 $76,436,064 +$15,827,475 $1.05 52
2024 Q3 56,682,696 $111,154,599 -$854,175 $1.96 42
2024 Q2 57,034,586 $114,325,460 +$107,182,399 $2.00 34
2024 Q1 3,935,132 $5,430,813 +$524,452 $1.38 25
2023 Q4 3,558,639 $4,020,714 +$1,102,318 $1.13 24
2023 Q3 2,578,656 $3,893,359 +$507,040 $1.51 23
2023 Q2 2,239,166 $3,582,021 +$1,631,639 $1.60 22
2023 Q1 1,276,355 $717,889 -$1,585,759 $0.56 20
2022 Q4 3,883,345 $2,545,096 -$383,818 $0.65 23
2022 Q3 4,130,839 $4,587,000 +$1,461,710 $1.11 21
2022 Q2 2,747,803 $5,761,000 -$388,653 $2.12 17
2022 Q1 2,904,420 $6,302,000 -$2,229,327 $2.17 12
2021 Q4 3,549,370 $9,441,000 +$8,486,000 $2.66 16